3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Post-stroke Spasticity: new trials by email Literature Review of Post-stroke Spasticity trials Research Report on Post-stroke Spasticity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dysport® Adult Lower Limb Spasticity Follow-on Study Botulinum toxin type A - Post-stroke Spasticity, Spasticity Post-Traumatic Brain Injury | Phase 3 | Completed | Ipsen | 352 | 2011-06-01 | 2022-09-28 |
| Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity GSK1358820, Placebo - Post-Stroke Spasticity, Cerebrovascular Accident | Phase 3 | Completed | GlaxoSmithKline | 109 | 2007-05-01 | 2017-05-30 |
| Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity GSK1358820, Placebo - Post-Stroke Spasticity, Cerebrovascular Accident | Phase 3 | Completed | GlaxoSmithKline | 120 | 2007-05-01 | 2010-09-08 |
Muscle Spasticity (2) · Stroke (2)
Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Muscle Hypertonia (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Neuromuscular Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Vascular Diseases (2)
Botulinum Toxins, Type A (1) · abobotulinumtoxinA (1)
GlaxoSmithKline (2) · Ipsen (1)
Japan (2) · Australia (1) · Belgium (1) · Czechia (1) · France (1) · Hungary (1) · Italy (1) · Poland (1) · Portugal (1) · Russia (1) · Slovakia (1) · United States (1)
PMID 20358216, PMID 20569068, PMID 29093068, PMID 31529136, PMID 32108436, PMID 32741133
2009 (1)